Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,811 | 23,940 | 49,630 | 1,700 | 2,020 |
| Marketable Securities | 164,869 | 182,380 | 161,000 | 6,920 | 7,130 |
| Receivables | 2,815 | 2,360 | 1,480 | 1,550 | 3,390 |
| Other current assets | 0 | 50 | 50 | 70 | 80 |
| TOTAL | $206,032 | $208,730 | $212,160 | $10,240 | $12,620 |
| Non-Current Assets | |||||
| PPE Net | 14,477 | 16,640 | 13,820 | 12,920 | 12,470 |
| Other Non-Current Assets | 184 | 670 | 290 | 1,380 | 280 |
| TOTAL | $14,661 | $17,310 | $14,110 | $14,300 | $12,750 |
| Total Assets | $220,693 | $221,110 | $222,040 | $20,920 | $22,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,012 | 870 | 880 | 880 | 870 |
| Accounts payable and accrued liabilities | 2,523 | 2,320 | 1,660 | 1,970 | 1,190 |
| Accrued Expenses | 3,024 | 0 | 0 | 0 | 0 |
| Other current liabilities | N/A | 3,500 | 6,980 | 7,850 | 8,210 |
| TOTAL | $11,231 | $6,700 | $9,550 | $10,780 | $10,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,834 | 2,210 | 2,420 | 2,630 | 3,570 |
| Deferred Revenues | 4,672 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 660 | 0 |
| TOTAL | $1,834 | $2,210 | $2,420 | $3,294 | $3,576 |
| Total Liabilities | $13,065 | $8,910 | $11,970 | $14,090 | $14,180 |
| Shareholders' Equity | |||||
| Common Shares | 48 | 40 | 40 | 20 | 20 |
| Retained earnings | -54,903 | -47,380 | -45,840 | -42,320 | -28,900 |
| Other shareholders' equity | -33,637 | -36,470 | -46,240 | -19,310 | 29,130 |
| TOTAL | $207,628 | $212,190 | $210,070 | $6,820 | $8,110 |
| Total Liabilities And Equity | $220,693 | $221,100 | $222,040 | $20,910 | $22,290 |